The transcriptional activity of genes largely depends on the accessibility of specific chromatin regions to transcriptional regulators. This process is controlled by diverse post-transcriptional modifications of the histone amino termini of which reversible acetylation plays a vital role. Histone acetyltransferases (HATs) 
Histone-dependent mode of action

HDAC-1 and HDAC-2 as well as other HDACs do not act autonomously but create multi-subunit protein complexes
. Because they lack intrinsic DNA-binding activity, HDACs require DNA-binding proteins to localize specific genes destined for deacetylation-mediated transcriptional repression. At the same time, other protein components of the complex act as cofactors, augmenting the enzymatic activity of HDACs [13] . In fact, three HDAC1/2-containing corepressor complexes have been identified: (i) Sin3, (ii) the nucleosome remodeling and deacetylation complex (NuRD) and (iii) the corepressor of RE1-silencing transcription factor (coREST) [14, 15] . Another member of class I HDACs, namely HDAC-3, resides in a complex with the nuclear receptor corepressor (NCoR) and silencing mediator for retinoid and thyroid receptors (SMRT) [16, 17] . These HDAC-3 containing complexes also take part in interactions occurring within the HDAC family. SMRT/NCoR corepressors not only bind to class IIa HDACs but are also a prerequisite for their enzymatic activity [18, 19] .
HDAC-dependent deacetylation of histones affects gene transcription by at least two parallel mechanisms (Fig. 1) . As described before, histone deacetylation enhances the electrostatic interaction between the histone core of nucleosomes and DNA, leading to chromatin condensation [4] . Apart from altering the physical properties of chromatin, removal of acetyl groups modifies the array of posttranslational modifications of amino acids in histones' amino termini. These chemical modifications, including phosphorylation, acetylation, methylation, ubiquitination and sumoylation, are thought to create a specific code, designated as the histone code [2] . Addition or removal of a functional group on one amino acid residue may influence the status of neighbouring amino acid residues, not only in the same histone tail but also in tails of other histones, or even in other nucleosomes. As a result, the context of the encrypted message may be changed [13, 20] . This secret molecular language of chemical marks is deciphered by nuclear proteins such as transcription factors or chromatin modifying enzymes. These are endowed with specific recognition modules with bromo-and chromodomains that recognize acetylated sites or amino acids in methylated form, respectively [21, 22] . Depending on the nature of the recruited protein, a specific action will be initiated. Thus, although [23] [24] [25] . [26, 27] .) factors, DNA repair enzymes, cell-cycle regulators, molecular chaperones as well as structural proteins were found to be reversibly acetylated [28] . Acetylation/deacetylation may modify the stability of the protein involved, its localization, DNA-binding ability and its interactions with other proteins [29, 30] . Recently, a novel nomenclature was proposed for some of the chromatinmodifying enzymes, replacing the historical term of HATs by the more general one, of, 'lysine (K)-acetyltransferases' (KATs) [31] . Rethinking of our perception of KATs and HDACs seems necessary as their significance raises from transcriptome-related enzymes to proteome-controlling enzymes and finally to masters of the acetylome [29] .
we are used to associate histone deacetylation with chromatin inactivation, the factual effect on transcription not only depends on the net electric charge of all modifications on histone tails but also on the type of proteins, i.e. silencers or activators of transcription, recruited in response to acetyl group displacement. As a consequence HDACs may either positively or negatively affect gene expression. The latter was confirmed by the observations made in HDAC inhibitor (HDI)-treated systems, where a similar number of genes was found to be either upregulated or down-regulated upon the treatment
Furthermore, several independent groups reported the requirement of HDAC activity in the activation of transcription in cytokineinducible systems such as interferon-controlled genes. (For an extensive review of this topic we refer to
Cell cycle-related histone and non-histone substrates of histone deacetylases
The role of HDACs in cellular proliferation was emphasized by the discovery that their anomalous action constitutes a cornerstone of carcinogenesis, a process which results from a disrupted balance between cell proliferation and apoptosis, in favour of unlimited growth [10, 28, 29, 32] . Global loss of histone H4 acetylation is a common trait of cancer cells, indicating disruption of the acetylome's homeostasis [33] [10, 29, 37] [10, 30, 32, 38, 39] .
In [28] . Yet, the biological relevance of these observations remains elusive.
Protein 53 transcription factor
Another master regulator of cell cycle progression, of which the activity is modulated by reversible acetylation, is p53 (Fig. 2) [57] . A study by Imbriano and colleagues indicated that p53 also down-regulates the expression of genes lacking a p53-regulatory sequence [58] .
Instead, the promoter regions of these genes contain NF-Y-binding boxes (CCAAT). Following DNA damage, p53 recruits, in concert with the NF-Y transcription factor HDACs and represses cdk1 and cyclin B2 transcription. The ensuing outcome is a G2-phase cell cycle arrest. Chromatin immunoprecipitation experiments revealed the identity of the recruited HDACs. Although HDAC-1 was the first to associate with the investigated promoters, HDAC-4 and HDAC-5
followed with a temporal delay, possibly due to the time required for their translocation from the cytosol to the nucleus [58] .
Cyclin-dependent kinase inhibitor p21 Cip1
One of the most renowned target genes of the p53 pathway is p21 Cip1 [59, 60] . Its protein product negatively regulates cell cycle progression by inhibiting the activity of several cdk/cyclin complexes and blocking DNA replication [61] .
The first evidence of HDACs' participation in the regulation of p21
Cip1 expression was delivered by Lagger and colleagues [62] . [70] . [38, [72] [73] [74] [75] [76] [77] . It has also been suggested that HDIs could be helpful in combating infections with protozoan parasites [78] or with viruses, including HIV [79] [80] [81] . [86] .
Inhibition of histone deacetylases in liver cells
Physiological condition: effects of histone deacetylase inhibitors on primary hepatocytes
The in vivo regenerative response in the liver is manifested by a semi-synchronous cell-cycle re-entry of surviving hepatocytes, accompanied by an induction of a number of differentiationpromoting pathways [87, 88] [64, 65] . [64, 65, 101] [101] .
Recently, new light was shed on the role of HDAC-1 in the control of liver proliferation by Wang et al. [100]. They showed that in the quiescent liver of aged mice HDAC-1 protein was elevated and interacted with the negative regulator of liver proliferation, namely CCAAT-enhancer-binding protein (C/EBP)-␣. The latter guided the HDAC-1 enzyme to E2F-responsive gene promoters enabling deacetylation of local histones and subsequent transcriptional silencing of the corresponding genes. The expression of proliferation-specific transcription factors, i.e. Forkhead box M1 B (FoxM1B) and c-myc, was inhibited in the former manner reflecting a diminished ability of the liver to regenerate during the aging process. Furthermore, the observed increase of the HDAC-1 protein was cyclin D3-dependent and resulted from an intensified translation of HDAC-1 mRNA [100]. Surprisingly, HDAC-1 was also elevated in the liver of young mice undergoing partial hepatectomy (PH)
. Nonetheless, as opposed to the previous study, a related transcription factor, namely C/EBP-␤ acted as a primary HDAC-1 interaction partner instead of C/EBP-␣. Following PH, the HDAC-1-C/EBP-␤ complex repressed the transcription of the former C/EBP isoform, and by doing so abolished the C/EBP-␣-mediated block of liver proliferation [101]. A substantial role of HDAC-1 in this process was underlined by the fact that depletion of the enzyme by siRNA technology prevented cyclin D1 and PCNA induction upon PH, whereas C/EBP-␣ protein was expressed at high levels
Our research group has shown that apart from cell proliferation, HDACs also modulate other aspects of hepatocyte physiology. As such, exposure of cultured adult rat hepatocytes to TSA improved both their xenobiotic biotransformation capacities and albumin secretion, and their gap junctional intercellular communication [102] [103] [104] . Additionally, an increased survival rate of hepatocytes was seen in conventional monolayer cultures by delaying activation of programmed cell death pathways [104, 105] . [113] .
Pathophysiological condition Liver malignancy-hepatocellular carcinoma Hepatocellular carcinoma (HCC) is one of the most frequent and one of the five deadliest malignancies on a global scale [106]. Viral infection with hepatitis B and/or C, as well as chronic exposure to toxic compounds, lead to uncontrolled inflammation with consequent expansion of liver fibrosis/cirrhosis, creating favourable conditions for HCC development [107]. In current clinical practise, treatment options are limited to surgical resection and liver transplantation. Due to the scarcity of healthy liver transplants, only a limited number of patients can be treated. Fifty to 80% of the patients undergoing surgery will suffer from recurrence within 5 years from resection [108]. There is, however, a growing understanding of the molecular events that participate in hepatocarcinogenesis. They may include telomere shortening, evoking chromosomal instability, loss of cell cycle checkpoints (p53, Rb, IGF2R), activation of proliferation and survival promoting pathways (PI3K, ERK, Wnt/␤-catenin, NF-␤) as well as inhibition of apoptosis (imbalance in the pro-and anti-apoptotic members of the Bcl-2 family) [109-112]. Recently, a direct link between HDAC activity and HCC incidence was discovered. It was indeed found, that chronic hepatitis B virus patients, being carrier of the specific HDAC-10 sequence variant, HDAC10-589CϾT, run a higher risk of HCC development. Additionally, this specific allele demonstrates higher transcriptional activity probably suggesting that increased HDAC-10 expression could be one of the contributors to the carcinogenesis process
Although [125, 128, 129] . A common feature of the whole myofibroblast population, independent of cell origin, is the expression of the myogenic marker ␣-smooth muscle actin (␣-SMA) (Fig. 4) [86] . [130] have shown that cyclin D1 levels decline in hepatocytes whereas the expression of cdk inhibitors such as p15 and p16, increase in the progression of liver fibrosis [130] . Simultaneously, the chief profibrogenic cytokine transforming growth factor (TGF)-␤, produced by activated HSCs, is known to have detrimental effects on hepatocyte survival [131] . Impaired (Fig. 3) . TSAinduced alterations of actin dynamics preserved the actin cytoskeleton typical for quiescent HSCs. As a consequence, the migration ability of HSCs was severely affected [136] .
Damage to liver parenchyma induces a regenerative response that is characterized by three phases, namely initiation, perpetuation and resolution [127]. (i) During the initiation phase, injured hepatocytes, HSCs, bile duct cells and activated immune system cells secrete a plethora of pro-inflammatory mediators, rendering the surviving liver cells responsive towards cytokines and growth factors. (ii) In the perpetuation phase, the activated cells synthesize and excrete growth-promoting stimuli in a paracrine and autocrine manner. These enhance the signalling spiral aimed at promoting hepatocyte proliferation and extracellular matrix (ECM) deposition by HSCs/myofibroblasts to replace the damaged tissue. (iii) It is speculated that upon restoration of proper liver architecture, activated HSCs may reverse to a quiescent state or undergo spontaneous apoptosis, accompanied by degradation of the ECM
Fig. 3 (A) Schematic representation of the cell cycle and cell cycle-related targets of HDIs described in liver cells. Positive or negative effect of HDIs on the expression/activity of cell cycle-specific proteins or events is indicated by a 'ϩ' or '-' sign respectively. (B) Summary of biological effects of
The authenticity of the above described findings was confirmed in other in vitro systems. The disproportionate deposition of ECM leading to fibrotic changes is not a unique feature of the fibrotic liver, [127] .
Fig. 4 Schematic representation of HSC activation. Liver damage (caused by viral infection, metabolic disease, drugs, toxins, cholestasis) leads to the transdifferentiation of quiescent HSCs into activated myofibroblast-like cells under the influence of different mediators secreted by resident liver cells as well as non-liver resident cells. The most striking phenotypical changes are the loss of lipid droplets, fibrogenesis and the increase in contractile capacity. During resolution of liver damage, it is not yet clear what the fate of the activated stellate cells is: re-differentiation into quiescent HSCs or apoptosis of the activated myofibroblast-like cells. Abbreviations not appearing in the text of the current review are: platelet derived growth factor (PDGF), endothelin 1 (ET-1), reactive oxygen species (ROS) and monocyte chemotactic protein 1 (MCP-1). The figure has been adapted from
but rather a common component of a group of disorders which may assault eye, kidney, lung and heart. The main perpetrators in these cases are fibroblasts that undergo a transdifferentiation process. The latter is analogous to that of HSCs in the damaged liver and also gives rise to myofibroblast-like cells [137] . The myofibroblastic phenotype may be mimicked in vitro by stimulating cultured fibroblasts with TGF-␤. Several studies describe that HDIs are able to inhibit TGF-␤-induced transformation of human, murine and rat skin fibroblasts in culture [138] [139] [140] (Fig. 2) 
